Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen Jackson

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
International Journal of Pharmaceutical Compounding|December 15, 2023
Drug Utilization Review: Our Patients Deserve Our Very BestKathleen Jackson
International Journal of Pharmaceutical Compounding|June 22, 2016
Root Cause Analysis, Part 2: STERILE COMPOUNDINGJoe Cabaleiro, Kathleen Jackson
Journal of Law and Medicine|September 24, 2009
Full steam ahead on the SS "external regulator"? Mandatory reporting, professional independence, self-regulation and patient harmKathleen Jackson, Malcolm Parker
International Journal of Pharmaceutical Compounding|February 20, 2016
Root Cause Analysis, Part 1: Nonsterile CompoundingJoe Cabaleiro, Kathleen Jackson
Transplantation|June 27, 2008
Prospective monitoring of BK polyomavirus infection early posttransplantation in nonrenal solid organ transplant recipientsKaren E Doucette, Xiaoli L Pang, Kathleen Jackson, et al.
Clinical Transplants|June 24, 2011
Lung and heart lung transplantation at the University of Alberta 1986-2010Dale C Lien, Justin Weinkauf, Kathleen Jackson, et al.
Patient Related Outcome Measures|August 24, 2012
The use of patient-reported outcomes becomes standard practice in the routine clinical care of lung-heart transplant patientsMaria J Santana, David Feeny, Justin Weinkauf, et al.
Head & Neck|October 31, 2012
Evaluation of optical coherence tomography to discriminate lesions of the upper aerodigestive tractVeronika Volgger, Herbert Stepp, Stephan Ihrler, et al.
Health and Quality of Life Outcomes|October 6, 2010
The construct validity of the health utilities index mark 3 in assessing health status in lung transplantationMaria-Jose Santana, David Feeny, Sunita Ghosh, et al.
Gut|August 19, 2016
Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis BJulianne Bayliss, Lilly Yuen, Gillian Rosenberg, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
International Journal of Pharmaceutical Compounding|December 15, 2023
Drug Utilization Review: Our Patients Deserve Our Very BestKathleen Jackson
International Journal of Pharmaceutical Compounding|June 22, 2016
Root Cause Analysis, Part 2: STERILE COMPOUNDINGJoe Cabaleiro, Kathleen Jackson
Journal of Law and Medicine|September 24, 2009
Full steam ahead on the SS "external regulator"? Mandatory reporting, professional independence, self-regulation and patient harmKathleen Jackson, Malcolm Parker
International Journal of Pharmaceutical Compounding|February 20, 2016
Root Cause Analysis, Part 1: Nonsterile CompoundingJoe Cabaleiro, Kathleen Jackson
Transplantation|June 27, 2008
Prospective monitoring of BK polyomavirus infection early posttransplantation in nonrenal solid organ transplant recipientsKaren E Doucette, Xiaoli L Pang, Kathleen Jackson, et al.
Clinical Transplants|June 24, 2011
Lung and heart lung transplantation at the University of Alberta 1986-2010Dale C Lien, Justin Weinkauf, Kathleen Jackson, et al.
Patient Related Outcome Measures|August 24, 2012
The use of patient-reported outcomes becomes standard practice in the routine clinical care of lung-heart transplant patientsMaria J Santana, David Feeny, Justin Weinkauf, et al.
Head & Neck|October 31, 2012
Evaluation of optical coherence tomography to discriminate lesions of the upper aerodigestive tractVeronika Volgger, Herbert Stepp, Stephan Ihrler, et al.
Health and Quality of Life Outcomes|October 6, 2010
The construct validity of the health utilities index mark 3 in assessing health status in lung transplantationMaria-Jose Santana, David Feeny, Sunita Ghosh, et al.
Gut|August 19, 2016
Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis BJulianne Bayliss, Lilly Yuen, Gillian Rosenberg, et al.
Pageof 2